Samsung Biologics Names John Rim as President and CEO
December 16, 2020 — 20:00 CST
This Data Is Locked!
This area is available only to Subscribers.
INCHEON, South Korea, Dec. 16, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced John Rim as its President and CEO. The appointment was made effective... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
